Your Location:
Home >
Browse articles >
Effect of Scutellariae Radix-Coptidis Rhizoma on Stabilization of Atherosclerotic Vulnerable Plaques via Inhibition of TLR4/MyD88/NF-κB Signaling Pathway
Updated:2024-09-26
    • Effect of Scutellariae Radix-Coptidis Rhizoma on Stabilization of Atherosclerotic Vulnerable Plaques via Inhibition of TLR4/MyD88/NF-κB Signaling Pathway

    • “The latest research found that Scutellaria baicalensis and Coptis chinensis could reduce plaque vulnerability in atherosclerotic mice by inhibiting TLR4/MyD88/NF - κ B signaling pathway, providing a new strategy for treating atherosclerosis.”
    • JI Lingyun , WU Qiaolan , CHEN Zetao , GE Chunlei , CHEN Weida , SONG Ting
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 13, Pages: 28-36(2024)
    • DOI: 10.13422/j.cnki.syfjx.20240236     

      CLC:

    Scan QR Code

  •  
  •  
  • AI Introduction

  • Full Text(HTML)

  • Figs( 4 ) Tabs( 6 )

  • References

  • Publication Info

  • Metrics

614

Views

202

Downloads

5

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Mechanism of Huoxin Pills in Stabilizing Atherosclerotic Vulnerable Plaque Based on Network Pharmacology and Metabolomics
Pharmacological Effect and Microscopic Mechanisms of Shenling Baizhu San
Mechanisms of Jiangtang No. 3 Prescription in Alleviating Adipose Tissue Insulin Resistance in Diabetic Rats via TLR4/NF-κB/NLRP3 Signaling Pathway-mediated Inflammation
Scutellariae Radix-Coptidis Rhizoma Treats Atherosclerosis via NLRP3 Inflammasome-mediated Pyroptosis of Macrophages
Clinical Efficacy of Modified Linggui Zhugan Tang in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome of Spleen Deficiency and Dampness Obstruction with Blood Stasis Type and Its Effect on MIF, miR-223, and IL-18

Related Author

XIANG Jiao
LUO Jieying
LIAO Daiyuan
LI Fulai
YI Rui
LIANG Yong
MO Zunhui
LIU Dongyan

Related Institution

School of Chinese Materia Medica,Guangzhou University of Chinese Medicine
Baiyunshan Pharmaceutical General Factory, Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.
Guangzhou Caizhilin Pharmaceutical Co. Ltd.
Hunan University of Chinese Medicine
Hunan Provincial Hospital of Integrated Traditional Chinese and Western Medicine